CIAM
ALDX icon

Caitong International Asset Management’s Aldeyra Therapeutics ALDX Stock Holding History

Caitong International Asset Management’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.1K Buy
+10,863
New +$18.7K ﹤0.01% 941
2025
Q3 		– Sell
-430
Closed -$1.65K – 1903
2025
Q2 		$1.65K Buy
430
+259
+151% +$670 ﹤0.01% 1443
2025
Q1 		$983 Buy
+171
New +$1.01K ﹤0.01% 1578

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Caitong International Asset Management's ALDX Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Aldeyra Therapeutics (ALDX) in Q2 2026: 10,863 shares worth $23.1K. The stake represents ﹤0.01% of the portfolio and ranks #941 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in ALDX as recently as Q2 2025.

Caitong International Asset Management first reported a position in ALDX in Q1 2025 and has held it in 3 quarters since. 107 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • Caitong International Asset Management held 10,863 shares of Aldeyra Therapeutics worth $23.1K as of Q2 2026.
  • Aldeyra Therapeutics was a new Caitong International Asset Management position in Q2 2026.
  • Aldeyra Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #941 holding.
  • Caitong International Asset Management first reported a position in Aldeyra Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • 107 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.